Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on May 28, 2025

Male Infertility Market Projected to Reach 6.62 Billion by 2033 | DataM Intelligence
Male infertility market size reached US$ 4.33 Bn in 2024 and is expected to reach US$ 6.62 Bn by 2033, growing at a CAGR of 4.9% during 2025-2033. NEW YORK, NY, UNITED STATES, May 29, 2025 /EINPresswire.com/ -- The global male infertility market is …

Genetic Testing Market to Witness Robust Growth at a CAGR of 23.1% by 2033 | DataM Intelligence
Genetic Testing Market- Innovative technologies, shifting patient preferences, and supportive government policies fuel market expansion across key regions CALIFORNIA, CA, UNITED STATES, May 29, 2025 /EINPresswire.com/ -- The global genetic testing …

GCRC's Mike Robinson Joins Organizing Committee for Dubai's Global Breast Cancer Treatment Conference
Robinson is known around the world for his nonstop education on the Endocannabinoid System (ECS), and his willingness to help educate the Healthcare Industry SANTA BARBARA, CA, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- Mike Robinson, Founder of …

Taazaa Inc. Secures ISO 27001:2022 Certification, Reinforcing Commitment to Data Security for Clients
HUDSON, OH, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- Taazaa Inc., a leading product engineering and software development company, is proud to announce it has achieved ISO 27001:2022 certification, the globally recognized standard for Information …

Global Renin-Angiotensin-System RAS-Acting Agents Market Outlook 2025-2034: Growth Drivers, Share, And Trends
The Business Research Company’s Renin-Angiotensin-System RAS-Acting Agents Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- What Is The Projected Market …

Leading Driver In The Relapsing-Remitting Multiple Sclerosis Market 2025: Rise In Personalized Medicine Market
The Business Research Company’s Relapsing-Remitting Multiple Sclerosis Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- What Is The Projected Market Size …

Cyclosporine Global Market Report 2025: Sweeping Across the Globe with Heightened Demand and Market Growth
The Business Research Company's Cyclosporine Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores …

Personalized Medicine Biomarkers Market Report 2025: Size, Trends, and Growth Insights for Global Expansion
The Business Research Company’s Personalized Medicine Biomarkers Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research Company’s …

Rheumatic Heart Disease Global Market Report 2025: Key Players, Trends, and Growth Opportunities Unveiled
The Business Research Company's Rheumatic Heart Disease Global Market Report 2025: Key Players, Trends, and Growth Opportunities Unveiled LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest …

Rhinovirus Infections Drug Market Report 2025: Size, Trends, and Growth Insights for Global Expansion
The Business Research Company's Rhinovirus Infections Drug Market Report 2025: Size, Trends, and Growth Insights for Global Expansion LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest …

Global CTLA4 Inhibitors Market Forecast: Key Growth Drivers, Trends, and Opportunities from 2025 to 2034
The Business Research Company's CTLA4 Inhibitors Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report …

Key Trend Shaping The Radiation Oncology Market In 2025: Advanced Radiation Therapy Systems Enhancing Patient Outcomes
The Business Research Company’s Radiation Oncology Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- What Is The Forecasted Growth Of The Radiation Oncology …

Personalized Or Customized Skin Care Global Market Report 2025
The Business Research Company’s Personalized Or Customized Skin Care Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research Company’ …

Global Retractable Needle Safety Syringes Market Insights 2025: Key Trends, Market Size, And Growth Forecast
The Business Research Company's Global Retractable Needle Safety Syringes Market Insights 2025: Key Trends, Market Size, And Growth Forecast LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research Company’s …

ATMOS Global Launches QuantumPrinciple Executive Advisors: a Pioneering Executive Search Firm for CEOs & Board Directors
ATMOS Global™ 's "QuantumPrinciple Executive Advisors™ " delivers innovative, data-driven solutions for board and CEO recruitment in a changing world. MELBOURNE, VICTORIA, AUSTRALIA, May 28, 2025 /EINPresswire.com/ -- ATMOS Global Pty Ltd (ATMOS Global …

Retinal Detachment Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034
The Business Research Company's Retinal Detachment Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report …

Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with Schizophrenia at American Society of Clinical Psychopharmacology 2025
Tokyo, Japan and Cambridge, UK, 29 May 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) notes that Neurocrine Biosciences, Inc. announced that it had presented new positive data from the Phase 2 study of NBI-1117568 in adults with …

CORRECTION: Streamex and BioSig Appoint Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (CIO)
Los Angeles, CA and Vancouver, BC, May 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig") and Streamex Exchange Corporation ("Streamex"), collectively referred to as the combined company, today announced the appointment of …

Rakovina Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations
VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”) announces that in accordance with the terms of an indenture entered into between the Company and Odyssey Trust …

Fate Therapeutics Announces Phase 1 Data Presentation of FT819 Off-the-Shelf CAR T-cell Product Candidate for SLE at EULAR 2025 Congress
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular …